The abstract is read at the publisher; the summary is JClub's.
FMO2+ salivary gland fibroblasts in Sjögren’s Disease show the strongest interferon-responsive gene signature and engage myeloid ligand-receptor interactions in patient tissue.
- Why it matters: Fibroblast heterogeneity in Sjögren’s Disease is not well defined, limiting understanding of which subsets drive onset, progression, and symptoms such as pain.
- What they did: The authors analyzed 3′ single-cell RNA sequencing from minor salivary gland biopsies (SjD n=17; controls n=19; 58,205 vs 33,584 cells) and validated findings with immunofluorescence, primary fibroblasts, mouse dorsal root ganglion assays, in vivo models, and spatial transcriptomics.
- The result: KILON+ fibroblasts uniquely expressed nerve/axon-associated transcripts, and Kilon treatment sensitized mouse dorsal root ganglia neurons in vitro (p≤0.01) and increased pain sensitivity in vivo (p≤0.01).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.